The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Abstract Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as alternatives to classical monotarget therapies and microRNAs are of particular interest in that regard. MicroRNA research has come a long way from their initial discovery to the cumulative appreciation...
Guardado en:
Autores principales: | Hannah Walgrave, Lujia Zhou, Bart De Strooper, Evgenia Salta |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e43a11d9d7444dbc9f5e8a4b95efafba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
por: Longfei Jia, et al.
Publicado: (2021) -
Profiling of Differentially Expressed MicroRNAs in Saliva of Parkinson's Disease Patients
por: Yanyan Jiang, et al.
Publicado: (2021) -
Circulating microRNAs in Symptomatic and Asymptomatic Carotid Stenosis
por: Gerrit M. Grosse, et al.
Publicado: (2021) -
MicroRNA-27b Expression in Rats Submitted to Physical Exercise and Experimental Cerebral Ischemia
por: De-Russi,Brenno Marco, et al.
Publicado: (2021) -
MicroRNA-Related Strategies to Improve Cardiac Function in Heart Failure
por: Huatao Zhou, et al.
Publicado: (2021)